Author

R. A. Everley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

S. A. Boswell· 2 shared A. C. Palmer· 1 shared A. E. Ringel· 1 shared A. R. Erickson· 1 shared C. A. Jacobson· 1 shared C. Chen· 1 shared C. E. Mills· 1 shared C. Liu· 1 shared

Activity by Year

2018-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

S. A. Boswell

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming

H. Wang, R. P. Sheehan, A. C. Palmer, R. A. Everley, S. A. Boswell, N. Ron-Harel, A. E. Ringel, K. M. Holton, C. A. Jacobson, A. R. Erickson, L. Maliszewski, M. C. Haigis, P. K. Sorger

Cell Systems · May 1, 2019Peer-reviewedPharmacology & Toxicology

Multi-omics profiling establishes the polypharmacology of FDA Approved CDK4/6 inhibitors and the potential for differential clinical activity

M. Hafner, C. E. Mills, K. Subramanian, C. Chen, M. Chung, S. A. Boswell, R. A. Everley, C. Liu, C. S. Walmsley, D. Juric, P. Sorger

This study compares the mechanisms of three FDA-approved CDK4/6 inhibitors and finds significant differences in their transcriptional, proteomic, and cellular effects, suggesting potential for differential clinical use.

bioRxiv · Mar 19, 2019Cancer Biology

EFCAB9 is a pH-Dependent Ca2+ Sensor that Regulates CatSper Channel Activity and Sperm Motility

J. Y. Hwang, N. Mannowetz, Y. Zhang, R. A. Everley, S. Gygi, J. Bewersdorf, P. Lishko, J.-J. Chung

This study identifies EFCAB9 as a pH-dependent Ca2+ sensor that modulates CatSper channel activity and sperm motility through its interaction with CATSPERζ.

bioRxiv · Nov 1, 2018Cell Biology